China

1. Abstract Breast cancer is the most prevalent cancer among women globally. Within breast cancer, the HR+/HER2+ subtype is particularly notable among luminal subtypes, as it shows resistance to both endocrine and anti-HER2 therapies. This is especially true for cases with local visceral metastasis, where the necessity of adding local therapy.

1. Abstract 1.1. Objective This study aims to investigate the clinical characteristics, timing of intervention, diagnostic and treatment options, and prognostic factors in patients with iTTP

1. Abstract Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitors (ALK TKIs) are highly effective in treating ALK-positive patients with advanced non-small cell lung cancer (NSCLC). However.

1. Abstract A case of primary immune thrombocytopenia (ITP) was reported, in which a patient developed intracranial venous sinus thrombosis accompanied by subarachnoid hemorrhage during oral administration of 25 mg/d of Eltrombopag. The patient discontinued the use of Eltrombopag and received symptomatic treatment with active anticoagulation, resulting in significant improvement.